E. B. C. Barroso, M. C. de Souza, S. R. C. de Araujo, and S. Crocamo, “Dual anti-human epidermal growth factor receptortype 2 blockade with taxane as first-line treatment for HER2-positive breast cancer with visceral metastases: a technology incorporation assessment within the Brazilian Unified Health System”, MAST, vol. 35, no. suppl.1, Feb. 2026.